- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06111092
Testare la metodologia del Design Thinking per coinvolgere nella ricerca le famiglie ispaniche e latine di bambini autistici.
The goal of this study is to compare two methods of engagement in research that include autistic individuals, Hispanic and Latino parents of autistic children, occupational therapy clinicians, teachers, and to use the information collected in the sessions to culturally adapt the occupational therapy Ayres Sensory Integration intervention to improve participation and health outcomes.
The main questions it aims to answer are:
Does the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaptations using DT data yield higher acceptability and implementation feasibility scores than FG methods?
Participants will:
- Be randomized into two groups of engagement (focus groups and design thinking)
- Be blinded (clinicians, selected caregivers, autistic persons, and cultural experts) and will rate the culturally adapted manualized protocol and evaluate the acceptability, feasibility, and cultural appropriateness of each protocol based on DT data, higher than the protocol based on FG data.
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Racial and ethnic minorities with autistic children experience delays in access to therapy services that can result in poorer outcomes, decreased quality of life, and increased parental and financial stress. Many autism interventions were developed and tested with only White participants, assuming they could be transferable to minority populations. However, research has found that this is not the case and that interventions that are not adapted to an individual's culture and ethnicity do not work as well and are not used as frequently. In this project, we compare two methods of stakeholder engagement, Design Thinking (DT) and Focus Groups (FG), to determine which is better at getting input on the facilitators and barriers to access therapy for autistic children. We focus on Hispanics and Latinos as this is the largest minority group in the US, with one of the fastest-growing groups of autistic children. Our long-term objective is to improve the functional skills and health of Hispanic/Latino autistic children and their families by improving access to an occupational therapy intervention designed to improve daily living skills, socialization, and quality of life. Occupational therapy using Ayres Sensory Integration (OT/ASI) is the only evidence-based intervention that addresses the sensory symptoms in autism. We will use input from these engagement sessions to adapt two versions of the OT/ASI manual: one using DT data and the other using FG data. Outcomes are evaluated following each step. Following the completion of this project, the planned outputs of the study are data on the most effective minority stakeholder engagement method and a culturally adapted OT/ASI manual for Hispanic and Latino autistic children for clinicians and researchers. This information can support future researchers who are engaging Hispanic/Latino individuals or other minority groups in research.
Methods: A randomized mixed methods design is used to evaluate stakeholder engagement methods. Phase one will compare two stakeholder engagement methods (Design Thinking -DT, and Focus Group - FG) and evaluate stakeholder engagement based on the PCORI areas of stakeholder engagement which are operationalized in the Stakeholder-Centric Engagement Evaluation and qualitative data. Phase two utilizes data from phase one to culturally adapt the intervention (two separate intervention protocols will be adapted - one based on FG data and another based on DT data as described below), and obtain stakeholder input on acceptability and feasibility for the Hispanic/Latino autistic population. This provides a second way to measure the effectiveness of each stakeholder engagement method as we will have data to indicate which method (DT or FG) resulted in the highest-rated protocol. The data provided by this study will be used as a basis for a later comparative effectiveness study that will study the culturally adapted protocol's outcomes.
All sessions will be held in Spanish and/or English based on the groups' preferences. Since our intent is to hear the voices of Hispanic/Latino stakeholders, it seems valuable to hold focus groups in Spanish when the participants are Spanish as first language speakers (hereafter referred to as Spanish-first) with audio recordings and later transcription into English for analysis. To accommodate those who prefer English, we will make every effort to group these participants together. When, and if, the Spanish-first groups include participants who prefer English, we will have a Spanish to English translator available. In other words, we will be respectful of each participant's language to optimize their comfort in the engagement sessions.
This project addresses an urgent need to engage stakeholders as part of the research process from conceptualization to dissemination and the need for culturally sensitive evidence-based interventions for Hispanic/Latino autistic children. This project is being developed by a skilled and experienced team of investigators.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Stati Uniti, 19107-5084
- Thomas Jefferson University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Autistic person:
- confirmed diagnosis of autism spectrum disorder
- Hispanic/Latino
- received therapeutic services as a child; and
- willing and able (with i.e., language and cognitive skills) to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
-
Parent/caregiver:
- Hispanic/Latino caregiver of an autistic child who receives or received therapeutic services such as occupational, physical, speech and language therapy
- willing to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
-
Exclusion Criteria:
- Do not meet age for autistic individual or diagnostic criteria
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Altro: Design Thinking Group
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Design Thinking (DT) process. |
Participants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test. |
|
Altro: Focus Group
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Focus Group (FG) process. |
Participants attend the FG that includes the introduction. discussion, and reflection. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Stakeholder-Centric Engagement Evaluation (S-CEE) (Martinez et al., 2021)
Lasso di tempo: Immediately following the one time engagement session
|
The Stakeholder-Centric Engagement Evaluation (S-CEE) is a measure used to assess the frequency and perceived quality of stakeholder engagement across 10 engagement domains, including: collaboration, communication, inclusion, transparency, learning, organizational structure, dissemination, and responsiveness to input. The measure evaluates two dimensions of engagement: frequency ("How Often") and quality ("How Well"). Each item is rated using a 5-point Likert scale. For "How Often," response options range from 1 ("Never") to 5 ("Always"). For "How Well," response options range from 1 ("Poor") to 5 ("Excellent"). Higher scores indicate greater frequency and higher perceived quality of stakeholder engagement. The S-CEE was administered to all participants immediately following the one-time engagement session to capture their perceptions of engagement. |
Immediately following the one time engagement session
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and the Feasibility of Intervention Measure (FIM) (Weiner et al., 2017)
Lasso di tempo: Immediately following the cultural adaptation reviews.
|
The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) are validated implementation outcome measures used to assess acceptability, appropriateness, and feasibility of the culturally adapted intervention based on the discussions in the focus groups and design thinking engagement sessions to improve access, use of therapy services, and strategies to adapt an evidence-based therapy intervention. AIM includes 5 items assessing the perceived acceptability of the intervention, IAM includes 4 items assessing the perceived appropriateness or fit of the intervention, and FIM includes 4 items assessing the perceived feasibility of implementing the intervention. Each item is rated using a 5-point Likert scale ranging from 1 ("Completely disagree") to 5 ("Completely agree"). Higher scores indicate greater perceived acceptability, appropriateness, and feasibility of the culturally adapted intervention. |
Immediately following the cultural adaptation reviews.
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Roseann C Schaaf, Thomas Jefferson University
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Disordini mentali
- Disturbi del neurosviluppo
- Disturbi dello sviluppo infantile, pervasivi
- Comportamento
- Aderenza e conformità al trattamento
- Comportamento sanitario
- Accettazione dell'assistenza sanitaria da parte del paziente
- Disturbo dello spettro autistico
- Disturbo autistico
- Partecipazione del paziente
- Qualità, accesso e valutazione dell'assistenza sanitaria
- Tecniche investigative
- Metodi epidemiologici
- Raccolta dei dati
- Meccanismi di valutazione dell'assistenza sanitaria
- Qualità dell'assistenza sanitaria
- Sanità pubblica
- Ambiente e salute pubblica
- Focus group
Altri numeri di identificazione dello studio
- 2022C2-28939
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Publications in high-impact autism and occupational therapy journals and presentations at national and international autism research meetings.
Periodo di condivisione IPD
Some de-identified data will be available following completion of the study and publication of findings.
Criteri di accesso alla condivisione IPD
Upon written request (reviewed by the principal investigator) information will be shared.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .